INS and type 2 diabetes mellitus: Whether patients with T2DM are treated with insulin or not, all patients are at risk of repeated revascularization but however, studies have shown a higher risk of repeated revascularization among patients within the ITDM group indicating that insulin therapy could partly be responsible or could act as an adjuvant thus contributing to such outcomes.